These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3946978)

  • 1. Amiodarone hepatotoxicity. A clinicopathologic study of five patients.
    Rigas B; Rosenfeld LE; Barwick KW; Enriquez R; Helzberg J; Batsford WP; Josephson ME; Riely CA
    Ann Intern Med; 1986 Mar; 104(3):348-51. PubMed ID: 3946978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal hepatotoxicity following oral administration of amiodarone.
    Richer M; Robert S
    Ann Pharmacother; 1995 Jun; 29(6):582-6. PubMed ID: 7663029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients.
    Lewis JH; Ranard RC; Caruso A; Jackson LK; Mullick F; Ishak KG; Seeff LB; Zimmerman HJ
    Hepatology; 1989 May; 9(5):679-85. PubMed ID: 2785079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone-induced reversible and irreversible hepatotoxicity: two case reports.
    Tsuda T; Tada H; Tanaka Y; Nishida N; Yoshida T; Sawada T; Sakata K; Hayashi K; Kawashiri MA; Oyama T; Sasaki M; Kurose N; Yamagishi M
    J Med Case Rep; 2018 Apr; 12(1):95. PubMed ID: 29653592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone-associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical, and electron microscopic studies.
    Poucell S; Ireton J; Valencia-Mayoral P; Downar E; Larratt L; Patterson J; Blendis L; Phillips MJ
    Gastroenterology; 1984 May; 86(5 Pt 1):926-36. PubMed ID: 6706074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathologic analysis of suspected amiodarone hepatotoxicity.
    Lewis JH; Mullick F; Ishak KG; Ranard RC; Ragsdale B; Perse RM; Rusnock EJ; Wolke A; Benjamin SB; Seeff LB
    Hum Pathol; 1990 Jan; 21(1):59-67. PubMed ID: 2403975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone hepatotoxicity simulating alcoholic liver disease.
    Simon JB; Manley PN; Brien JF; Armstrong PW
    N Engl J Med; 1984 Jul; 311(3):167-72. PubMed ID: 6738602
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acute hepatopathy caused by amiodarone. Study of a case and review of the literature].
    Capron-Chivrac D; Reix N; Quénum C; Capron JP
    Gastroenterol Clin Biol; 1985; 9(6-7):535-9. PubMed ID: 4018488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased hepatic density and phospholipidosis due to amiodarone.
    Goldman IS; Winkler ML; Raper SE; Barker ME; Keung E; Goldberg HI; Boyer TD
    AJR Am J Roentgenol; 1985 Mar; 144(3):541-6. PubMed ID: 3871563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of amiodarone hepatic and pulmonary toxicity to serum drug concentrations and superoxide dismutase activity.
    Pollak PT; Sharma AD; Carruthers SG
    Am J Cardiol; 1990 May; 65(18):1185-91. PubMed ID: 2337027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiodarone and the liver.
    Tordjman K; Katz I; Bursztyn M; Rosenthal T
    Ann Intern Med; 1985 Mar; 102(3):411-2. PubMed ID: 3970484
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatotoxicity of amiodarone.
    Rumessen JJ
    Acta Med Scand; 1986; 219(2):235-9. PubMed ID: 3962737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatotoxicity of amiodarone in rats].
    Camps DH; Sánchez C; Holtz RM
    Medicina (B Aires); 1986; 46(3):320-6. PubMed ID: 3574091
    [No Abstract]   [Full Text] [Related]  

  • 14. Granular cells as a marker of early amiodarone hepatotoxicity: a pathological and analytical study.
    Shepherd NA; Dawson AM; Crocker PR; Levison DA
    J Clin Pathol; 1987 Apr; 40(4):418-23. PubMed ID: 3584485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amiodarone-induced acute hepatotoxicity.
    Rao U; Agarwal A
    Eur J Clin Pharmacol; 2012 Apr; 68(4):449-50. PubMed ID: 21989920
    [No Abstract]   [Full Text] [Related]  

  • 16. Amiodarone hepatotoxicity in the context of the metabolic syndrome and right-sided heart failure.
    Mattar W; Juliar B; Gradus-Pizlo I; Kwo PY
    J Gastrointestin Liver Dis; 2009 Dec; 18(4):419-23. PubMed ID: 20076813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of population modeling to define rational monitoring of amiodarone hepatic effects.
    Pollak PT; Shafer SL
    Clin Pharmacol Ther; 2004 Apr; 75(4):342-51. PubMed ID: 15060512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Amiodarone-induced liver dysfunctions].
    Gassanov N; Caglayan E; Erdmann E; Er F
    Dtsch Med Wochenschr; 2010 Jul; 135(27):1372-4. PubMed ID: 20589584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probable early acute hepatitis with parenteral amiodarone.
    Lupon-Rosés J; Simó-Canonge R; Lu-Cortez L; Permanyer-Miralda G; Allende-Monclús H
    Clin Cardiol; 1986 May; 9(5):223-5. PubMed ID: 3708949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic liver disease after low daily doses of amiodarone. Report of three cases.
    Babany G; Mallat A; Zafrani ES; Saint-Marc Girardin MF; Carcone B; Dhumeaux D
    J Hepatol; 1986; 3(2):228-32. PubMed ID: 3794303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.